export branded business, despite a decrease in export CMG and domestic branded.  Net profit in Q4/2017 was Baht 28 million, a decrease of 76% YoY due to 1) lower sales contribution of export pressuring

income 47.97 100.00 79.46 100.00 (39.63) Costs 18.79 39.17 42.14 53.03 (55.41) Administrative expenses, finance costs and share of loss from associates 37.52 78.22 29.56 37.20 26.93 Management benefit

- Translation- June 11, 2019 Subject: Notification the Acquisition of share of BS Myco Biotech Company Limited. (Additional Information Memorandum Concerning the Acquisition of Assets) To: Director and Manager

products as well as growth from some exiting products. Domestic branded was quite maintained.  Net profit in Q1/2018 was Baht 9 million, a decrease of 92% YoY due to 1) lower sales contribution of export

synthetic fatty alcohols price and also supply of natural fatty alcohols has slightly dwindled due to maintenance shutdown of some producers, hence demand for natural fatty alcohols was still in good

4,882.3 Earnings per Share (EPS) Baht 1.79 1.65 1.90 1.79 Total liability-to-equity ratio (D/E ratio) Times 1.31 1.43 1.57 1.79 Return on Equity (ROE) Percentage 12.10 11.03 12.55 15.247 Bangkok Commercial

ter 2 Quar ter 1-2 Profit Attributable to Owner of the Parent - Previously Reported 2,200.99 3,559.43 Finance Costs (Increase) / Decrease (114.61) (297.48) Share of Profit of Associates and Joint

Baht 2.96 million, increased from the same period last year by Baht 1.85 million, which mainly from share of profit from Absolute Yoga Co., Ltd. and Scentimental (Thailand) Co., Ltd. due to the

-o-Q and 29.6% Y-o-Y. Following the economic crisis facing the automotive industry due to COVID-19 and lock down measures implemented by many countries in which the Company operates, our customer

at key customers. These issues are resolved and with expected fixed asset investment due to the expected government stimulus and a new product, targeting steel customers, now ready this part of the